Search results
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
Investing.com· 6 days agoLungs of young adults more susceptible to SARS-CoV-2 virus: Study
Newly Discovered Prehistoric Snake May Be Largest To Ever Exist, Vaccine Breakthrough Could Mean...
IFLScience· 4 days agoThis week, a physicist studying the SARS-CoV-2 virus believes he’s found evidence that we’re living...
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
SciTechDaily· 2 days agoThe SARS-CoV-2 virus that causes COVID has the unsettling ability of often generating variants of...
Tri-State clinics and trials help patients with long COVID
Local 12 Cincinnati· 24 hours agoWhile new cases of the novel SARS-CoV-2 virus are down, infectious disease specialist Dr. Stephen...
COVID-19 virus disrupts protein production: Researcher discusses her recent findings
Phys.org· 2 hours agoOne thing we do know: Following infection, it's critical that our cells make new proteins to defend against the virus. Writer Jenni Bozec recently spoke with Yerlici—who is based in the lab ...
UK virtually ends free vaccines as COVID-19 continues to spread
World Socialist Web Site· 3 days agoConsequently, the SARS-COV-2 virus still infects tens of thousands weekly, leading to hundreds of...
Moderna seals vaccine deal with Brazil's Health Ministry By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) has secured a contract with Brazil's Ministry of Health to supply 12.5...
WHO clarifies terminology for air-transmitted pathogens
Medical Xpress· 6 days agoDuring the COVID-19 crisis the standoff between experts arguing over whether the SARS-CoV-2 virus...
COVID virus mutated in Dutch man, raising importance of proper immunocompromised care
Cosmos· 5 days agoForthcoming research from the group relates to a previously reported case of a 72-year-old Dutch man who was infected with the SARS-CoV-2
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 20 hours agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published April 16 in eLife ...